Am J Perinatol
DOI: 10.1055/a-2764-2151
Original Article

Timing and Severity of Fetal Growth Restriction Diagnosis and Association with Perinatal Morbidity

Authors

  • Lilian N. Bui

    1   Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
  • Sonia Ahluwalia

    2   Department of Obstetrics and Gynecology, University of Washington School of Medicine, Seattle, Washington, United States
  • Nkechinyelum Q. Ogu

    1   Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
  • Sydney L. Raucher

    1   Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
  • Emily S. Miller

    3   Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Women & Infants Hospital of Rhode Island, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, United States
  • Priya R. Rajan

    1   Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
  • Stephanie A. Fisher

    1   Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States

Funding Information The authors do not have funding relevant to this study to disclose.

Abstract

Objective

In 2020, the Society of Maternal Fetal Medicine refined fetal growth restriction (FGR) diagnostic criteria by temporal (early-, <32 weeks 0 days [320] weeks; late-onset, ≥320 weeks) and measurement-specific definitions (severe, estimated fetal weight <3rd; mild, estimated fetal weight 3rd–9th percentile and/or abdominal circumference <10th percentile). Using these updated clinical definitions, we sought to determine the association of timing and severity of FGR diagnosis with, and their discriminatory ability for, adverse pregnancy outcomes.

Study Design

This retrospective cohort study included singleton, non-anomalous pregnancies with sonographic FGR diagnosis at ≥180 weeks' gestation from May 2020 to December 2021. We evaluated four FGR classification exposure groups: (1) early-onset, severe FGR; (2) early-onset, mild FGR; (3) late-onset, severe FGR; and (4) late-onset, mild FGR. Outcomes assessed were hypertensive disorders of pregnancy, preterm birth, and small-for-gestational age. Multivariable logistic regression estimated the odds of each outcome associated with each exposure, adjusted for maternal age, insurance, and parity. Receiver-operating characteristic analysis determined test characteristics for the ability of these FGR classification groups to identify the postnatal outcomes, using late-onset, mild FGR as the reference group.

Results

Among 566 eligible pregnancies, early-onset, severe FGR had higher adjusted odds of hypertensive disorders of pregnancy (aOR = 1.3, 95% CI: 1.1–1.7), preterm birth (aOR = 2.1, 95% CI: 1.6–2.6), and small-for-gestational age (aOR = 1.6, 95% CI: 1.3–1.9), compared to late-onset, mild FGR. Late-onset, severe FGR also had higher adjusted odds of preterm birth (aOR = 7.2, 95% CI: 2.9–18.3) and small-for-gestational age (aOR = 5.8, 95% CI: 2.5–13.6). Odds of adverse pregnancy outcomes were similar with early- and late-onset mild FGR. Overall, discriminatory ability of these FGR classification groups for adverse pregnancy outcomes were poor.

Conclusion

Early- and late-onset, severe FGR (versus late-onset, mild FGR) are positively associated with, but have poor discriminatory ability for, adverse pregnancy outcomes.

Key Points

  • Early-onset, severe FGR (vs. late-onset, mild FGR) is significantly associated with hypertensive disorders of pregnancy.

  • Compared to late-onset mild FGR, severe FGR, whether early- or late-onset, has greater odds of preterm birth and small-for-gestational age.

  • All FGR classification groups had weak discriminatory ability for identification of these adverse pregnancy outcomes.

Note

This manuscript was presented as a poster at the American Institute of Ultrasound in Medicine Ultracon 2023 meeting from March 25 to 29, 2023 in Orlando, FL.




Publication History

Received: 19 September 2024

Accepted: 03 December 2025

Accepted Manuscript online:
15 December 2025

Article published online:
31 December 2025

© 2025. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Bodnar L, Himes K. Maternal nutrition. In: Resnik R, Lockwood C, Moore T, Greene M, Copel J, Silver R. eds. Creasy and Resnik's Maternal-Fetal Medicine: Principles and Practice. 8th ed.. Elsevier; 2019
  • 2 Martins JG, Biggio JR, Abuhamad A. Society for Maternal-Fetal Medicine (SMFM). Electronic address: pubs@smfm.org. Society for Maternal-Fetal Medicine Consult Series #52: diagnosis and management of fetal growth restriction: (Replaces Clinical Guideline Number 3, April 2012). Am J Obstet Gynecol 2020; 223 (04) B2-B17
  • 3 American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Obstetrics and the Society forMaternal-FetalMedicin. ACOG Practice bulletin no. 204: fetal growth restriction. Obstet Gynecol 2019; 133 (02) e97-e109
  • 4 Unterscheider J, O'Donoghue K, Daly S. et al. Fetal growth restriction and the risk of perinatal mortality-case studies from the multicentre PORTO study. BMC Pregnancy Childbirth 2014; 14: 63
  • 5 McIntire DD, Bloom SL, Casey BM, Leveno KJ. Birth weight in relation to morbidity and mortality among newborn infants. N Engl J Med 1999; 340 (16) 1234-1238
  • 6 Blue NR, Savabi M, Beddow ME. et al. The Hadlock method is superior to newer methods for the prediction of the birth weight percentile. J Ultrasound Med 2019; 38 (03) 587-596
  • 7 Hadlock FP, Harrist RB, Martinez-Poyer J. In utero analysis of fetal growth: a sonographic weight standard. Radiology 1991; 181 (01) 129-133
  • 8 Mascherpa M, Pegoire C, Meroni A. et al. Prenatal prediction of adverse outcome using different charts and definitions of fetal growth restriction. Ultrasound Obstet Gynecol 2024; 63 (05) 605-612
  • 9 Savchev S, Figueras F, Sanz-Cortes M. et al. Evaluation of an optimal gestational age cut-off for the definition of early- and late-onset fetal growth restriction. Fetal Diagn Ther 2014; 36 (02) 99-105
  • 10 Figueras F, Caradeux J, Crispi F, Eixarch E, Peguero A, Gratacos E. Diagnosis and surveillance of late-onset fetal growth restriction. Am J Obstet Gynecol 2018; 218 (2S): S790-S802 , 802.e1
  • 11 Aviram A, Sherman C, Kingdom J, Zaltz A, Barrett J, Melamed N. Defining early vs late fetal growth restriction by placental pathology. Acta Obstet Gynecol Scand 2019; 98 (03) 365-373
  • 12 Committee opinion no 700: methods for estimating the due date. Obstet Gynecol 2017; 129 (05) e150-e154
  • 13 Gordijn SJ, Beune IM, Thilaganathan B. et al. Consensus definition of fetal growth restriction: a Delphi procedure. Ultrasound Obstet Gynecol 2016; 48 (03) 333-339
  • 14 Roeckner JT, Pressman K, Odibo L, Duncan JR, Odibo AO. Outcome-based comparison of SMFM and ISUOG definitions of fetal growth restriction. Ultrasound Obstet Gynecol 2021; 57 (06) 925-930
  • 15 Gestational Hypertension and Preeclampsia. Gestational hypertension and preeclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol 2020; 135 (06) e237-e260
  • 16 de Onis M, Garza C, Onyango AW, Rolland-Cachera MF. le Comité de nutrition de la Société française de pédiatrie. [WHO growth standards for infants and young children]. Arch Pediatr 2009; 16 (01) 47-53
  • 17 Fenton TR, Kim JH. A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr 2013; 13: 59
  • 18 Pineles BL, Mendez-Figueroa H, Chauhan SP. Diagnosis of fetal growth restriction in a cohort of small-for-gestational-age neonates at term: neonatal and maternal outcomes. Am J Obstet Gynecol MFM 2022; 4 (05) 100672
  • 19 Inácio QAS, Araujo Júnior E, Nardozza LMM, Petrini CG, Campos VP, Peixoto AB. Perinatal outcomes of fetuses with early growth restriction, late growth restriction, small for gestational age, and adequate for gestational age. Rev Bras Ginecol Obstet 2019; 41 (12) 688-696
  • 20 Nwabuobi C, Odibo L, Camisasca-Lopina H, Leavitt K, Tuuli M, Odibo AO. Comparing INTERGROWTH-21st Century and Hadlock growth standards to predict small for gestational age and short-term neonatal outcomes. J Matern Fetal Neonatal Med 2020; 33 (11) 1906-1912
  • 21 Blue NR, Beddow ME, Savabi M, Katukuri VR, Chao CR. Comparing the Hadlock fetal growth standard to the Eunice Kennedy Shriver National Institute of Child Health and Human Development racial/ethnic standard for the prediction of neonatal morbidity and small for gestational age. Am J Obstet Gynecol 2018; 219 (05) 474.e1-474.e12
  • 22 Blue NR, Mele L, Grobman WA. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Predictive performance of newborn small for gestational age by a United States intrauterine vs birthweight-derived standard for short-term neonatal morbidity and mortality. Am J Obstet Gynecol MFM 2022; 4 (03) 100599
  • 23 Schreiber V, Hurst C, da Silva Costa F, Stoke R, Turner J, Kumar S. Definitions matter: detection rates and perinatal outcome for infants classified prenatally as having late fetal growth restriction using SMFM biometric vs ISUOG/Delphi consensus criteria. Ultrasound Obstet Gynecol 2023; 61 (03) 377-385
  • 24 Giouleka S, Tsakiridis I, Mamopoulos A, Kalogiannidis I, Athanasiadis A, Dagklis T. Fetal growth restriction: a comprehensive review of major guidelines. Obstet Gynecol Surv 2023; 78 (11) 690-708